Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2011-11-07

FDA Approved: LEVOCETIRIZINE DIHYDROCHLORIDE — Original Application (Padagis Israel Pharmaceuticals Ltd)

View source ↗

Summary

FDA approves the original application for levocetirizine dihydrochloride from Padagis Israel Pharmaceuticals Ltd, a generic antihistamine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levocetirizine dihydrochloride (LEVOCETIRIZINE DIHYDROCHLORIDE)

Snippet

ORIG AP for LEVOCETIRIZINE DIHYDROCHLORIDE (LEVOCETIRIZINE DIHYDROCHLORIDE)